Inge Vrelust

543 citations

13 papers · 94 indexed · h-index 6

Impact in

Immunology and Allergy
- Food Allergy and Anaphylaxis Research
Hematology
- Acute Myeloid Leukemia Research

Papers in ⓘ

Microbiology 1
Hematology 5
- Acute Myeloid Leukemia Research 3

Co-authors: Alain Gadisseur (8 shared papers)Luc S. De Clerck (1 shared paper)Didier G. Ebo (1 shared paper)Peter Valent (1 shared paper)Els Van de Vijver (1 shared paper)Erik Fransén (1 shared paper)Chris H. Bridts (1 shared paper)Margo M. Hagendorens (1 shared paper)
Journals: Blood (3 papers)Journal of Clinical Oncology (1 paper)Journal of Allergy and Clinical Immunology (1 paper)BMC Infectious Diseases (1 paper)Thrombosis and Haemostasis (1 paper)
Partner nations: Belgium Netherlands United States

In The Last Decade

Inge Vrelust

13 papers receiving 92 citations

Peers

Countries citing papers authored by Inge Vrelust

Since Specialization

Citations

This map shows the geographic impact of Inge Vrelust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Vrelust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Vrelust more than expected).

Fields of papers citing papers by Inge Vrelust

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Vrelust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Vrelust. The network helps show where Inge Vrelust may publish in the future.

Co-authors

The 25 scholars most cited alongside Inge Vrelust, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Inge Vrelust Line = papers co-authored together Inge Vrelust links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	Familial hypertryptasemia with associated mast cell activation syndrome Journal of Allergy and Clinical Immunology ·Vito Sabato, Els Van de Vijver, Margo M. Hagendorens, Inge Vrelust, Edwin Reyniers, Erik Fransén, Chris H. Bridts, Luc S. De Clerck, Geert Mortier, Peter Valent, Didier G. Ebo	2014	38
2	MEDICAL AND SURGICAL MANAGEMENT OF PARANEOPLASTIC PYODERMA GANGRENOSUM - A CASE REPORT AND REVIEW OF THE LITERATURE Acta Clinica Belgica ·S. Lamet, An Bracke, E. Geluykens, Erika Vlieghe, Katia Seymons, Alain Gadisseur, Inge Vrelust, Veerle Van Marck, Johan Somville, Jo Lambert	2010	9
3	Targeted next‐generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics International Journal of Laboratory Hematology ·Brigitte Maes, J. Willemse, An Broekmans, Rita Smets, Bert Cruys, Natalie Put, V. Madoe, M. Janssen, Otto Soepenberg, Greet Bries, Inge Vrelust, Ruth Achten, Kristien Van Pelt, Kristel Buvé, Koen Theunissen, V. Peeters, Guy Froyen	2017	7
4	Prevention Of Relapse In Acute Myeloid Leukemia By Dendritic Cell Vaccination: Report on a Phase II Study With 29 Patients Blood ·Zwi Berneman, Ann Van de Velde, Sébastien Anguille, Yannick Willemen, Wilfried Schroyens, Alain Gadisseur, Inge Vrelust, Griet Nijs, Barbara Stein, Nathalie Cools, Ronald Malfait, Marie-Berthe Maes, Katrien Vermeulen, Viggo Van Tendeloo, Evelien Smits	2013	7
5	Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey Acta Clinica Belgica ·Yves Béguin, D. Selleslag, Stef Meers, Carlos Graux, Greet Bries, Dries Deeren, Inge Vrelust, Christophe Ravoet, Koen Theunissen, Verena Voelter, H. Potier, Fabienne Trullemans, L. Noens, Philippe Mineur	2014	7
6	Phialemonium curvatum fungaemia in an immunocompromised patient: case report. PubMed ·Ben Persy, Inge Vrelust, Alain Gadisseur, Margareta Ieven	2012	6
7	A warning about agranulocytosis with the use of cocaine adulterated with levamisole. PubMed ·Stany Perkisas, Inge Vrelust, M Martín, Alain Gadisseur, W Schroyens	2011	5
8	WT1-targeted dendritic cell vaccination as a postremission treatment to prevent or delay relapse in acute myeloid leukemia. Journal of Clinical Oncology ·Zwi Berneman, Ann Van de Velde, Sébastien Anguille, Nathalie Cools, Ann Van Driessche, Griet Nijs, Barbara Stein, Inge Vrelust, Alain Gadisseur, Wilfried Schroyens, Viggo Van Tendeloo, Evelien Smits	2012	4
9	A hypogranular variant of acute promyelocytic leukaemia showing a heterogenic immunophenotype with CD34, CD2, HLA-DR positivity: a case report and review of the literature. PubMed ·Lisbeth Patteet, Katrien Vermeulen, Katrien Pieters, E. Van Assche, Inge Vrelust, A Gaddiseur, Zwi Berneman, Marc van der Planken	2012	4
10	Efficacy and Safety of Ponatinib in CML and Ph+ ALL Patients in Real-World Clinical Practice: Data from a Belgian Registry Blood ·Timothy Devos, Koen Theunissen, Fleur Samantha Benghiat, Alain Gadisseur, Stef Meers, Dominik Selleslag, Gaëtan Vanstraelen, Pierre Zachée, Marc André, Philippe Lewalle, Mia Janssen, Rik Schots, Koen Van Eygen, Alain Kentos, Marie Lejeune, A. Triffet, Inge Vrelust, Carolina Kuipers, Violaine Havelange	2018	3
11	Immunogenicity and Antileukemic Activity of Dendritic Cells Electroporated with Wilms’ Tumor WT1 mRNA: A Phase I/II Trial in Acute Myeloid Leukemia Blood ·Zwi Berneman, Ann Van de Velde, Ann Van Driessche, Nathalie Cools, Barbara Stein, Griet Nijs, Katrien Vermeulen, Katrien Pieters, Wilfried Schroyens, Alain Gadisseur, Inge Vrelust, I. Jolanda de Vries, David A. Price, Yusuke Oji, Haruo Sugiyama, Viggo Van Tendeloo	2008	2
12	More than meets the eye: Nocardia farcinica, Candida dubliniensis and Aspergillus spp. co-infection in a patient with multiple myeloma treated with multiple treatment regimens BMC Infectious Diseases ·Lotte Vrijders, Erwin Ho, D. Van der beek, Inge Vrelust, Heleen Nailis	2025	1
13	Identification of a novel candidate splice site mutation (0874+1G>A) in a type 3 von Willebrand disease patient Thrombosis and Haemostasis ·Inge Vrelust, Inge Vangenechten, Reinhard Schneppenheim, Marc van der Planken, Alain Gadisseur	2007	1

About Inge Vrelust

Inge Vrelust is a scholar working on Microbiology, Hematology, Genetics, Immunology and Periodontics, having authored 13 papers that have together received 94 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Acute Myeloid Leukemia Research (3 papers), Renal and related cancers (3 papers), Immunotherapy and Immune Responses (3 papers), Antifungal resistance and susceptibility (2 papers), RNA Interference and Gene Delivery (2 papers), Blood disorders and treatments (2 papers) and Fungal Infections and Studies (2 papers). The work is most often cited by research in Immunology and Allergy (19 citations), Hematology (25 citations), Immunology (41 citations), Genetics (16 citations) and Toxicology (5 citations). Inge Vrelust has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Alain Gadisseur, Luc S. De Clerck, Didier G. Ebo, Peter Valent, Els Van de Vijver, Erik Fransén, Chris H. Bridts, Margo M. Hagendorens, Edwin Reyniers and Geert Mortier. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology, BMC Infectious Diseases and Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact